Literature DB >> 35369108

Esther Veronika Wenzel1, Kilian Johannes Carl Zilkens1.   

Abstract

Despite readily available alternative technologies, many antibodies in research and diagnostics are still generated and produced with the use of laboratory animals. Here, we portrait the concept of animal-free recombinant antibodies and the generation of such an antibody against the spike-protein of SARS-Cov-2. The scientific community needs to raise awareness for more sustainable animal-free alternatives, especially as they offer a path to more reliable and reproducible data. © Springer-Verlag GmbH 2022.

Entities:  

Year:  2022        PMID: 35369108      PMCID: PMC8960684          DOI: 10.1007/s12268-022-1716-7

Source DB:  PubMed          Journal:  Biospektrum (Heidelb)        ISSN: 0947-0867


  4 in total

1.  Reproducibility: Standardize antibodies used in research.

Authors:  Andrew Bradbury; Andreas Plückthun
Journal:  Nature       Date:  2015-02-05       Impact factor: 49.962

2.  Animal-free alternatives and the antibody iceberg.

Authors:  Alison Gray; Andrew R M Bradbury; Achim Knappik; Andreas Plückthun; Carl A K Borrebaeck; Stefan Dübel
Journal:  Nat Biotechnol       Date:  2020-11       Impact factor: 54.908

3.  When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions.

Authors:  Andrew R M Bradbury; Nathan D Trinklein; Holger Thie; Ian C Wilkinson; Atul K Tandon; Stephen Anderson; Catherine L Bladen; Brittany Jones; Shelley Force Aldred; Marco Bestagno; Oscar Burrone; Jennifer Maynard; Fortunato Ferrara; James S Trimmer; Janina Görnemann; Jacob Glanville; Philipp Wolf; Andre Frenzel; Julin Wong; Xin Yu Koh; Hui-Yan Eng; David Lane; Marie-Paule Lefranc; Mike Clark; Stefan Dübel
Journal:  MAbs       Date:  2018-03-29       Impact factor: 5.857

Review 4.  Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.

Authors:  Mohamed A Alfaleh; Hashem O Alsaab; Ahmad Bakur Mahmoud; Almohanad A Alkayyal; Martina L Jones; Stephen M Mahler; Anwar M Hashem
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.